

How Atezolizumab Revolutionizes Cancer Treatment
Atezolizumab, marketed as Tecentriq, heralds a significant breakthrough in cancer treatment by leveraging the body’s immune system to target cancer cells through immune checkpoint inhibition. Approved for a spectrum of cancers like melanoma and NSCLC, its application in adjuvant and metastatic therapies showcases remarkable efficacy. Delve into Tecentriq’s administration, associated risks, and side effects to […]
3 min read